Page 29 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gide has advised the financial advisors SVB Securities, LifeSci Capital et Bryan, Garnier & Co in connection with the successful pricing of an oversubscribed Abivax €130 million financing with high-quality U.S. and European biotech specialist investors, by way of a reserved capital increase. This is the largest private placement of a biotech company listed only on Euronext Paris.

EQS-News: ABIVAX / Key word(s): Capital IncreaseAbivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors 22.02.2023 / 18:05 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR DISTRIBUTION IN OR INTO THE...

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR TO U.S. PERSONSAbivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US

The funds will support the development of Julier's thrombectomy solution for faster removal of blood clots and post-stroke revascularization all the way to first-in-humanPARIS, FRANCE / ACCESSWIRE / January

The 41st annual J.P. Morgan Healthcare Conference concluded last week. After the pandemic prompted it to go virtual, it was back in person, smaller in size and more effective. Here are my takeaways.